Lifestyle-related disease | Presence of treatment | Light drinkers (n = 344) | Non-drinkers (n = 797) | P-value (P a-value) |
---|---|---|---|---|
Hypertension | Treatment (+), n (%) | 128 (37.2Â %) | 330 (41.4Â %) | NS |
 | SBP (mmHg) | 130.5 ± 13.7 | 133.2 ± 15.7 | (NS) |
 | DBP (mmHg) | 77.3 ± 8.6 | 78.6 ± 9.2 | (NS) |
 | Treatment (−), n (%) | 216 (62.8 %) | 467 (58.6 %) |  |
 | SBP (mmHg) | 129.2 ± 13.0 | 130.6 ± 13.4 | (NS) |
 | DBP (mmHg) | 78.3 ± 9.7 | 77.6 ± 9.6 | (NS) |
Dyslipidemia | Treatment (+), n (%) | 85 (24.7Â %) | 320 (40.2Â %) | <0.01 |
 | T-CHO (mg/dl) | 197.8 ± 32.4 | 201.0 ± 26.5 | (NS) |
 | TG (mg/dl) | 116.3 ± 49.4 | 113.4 ± 52.6 | (NS) |
 | HDL (mg/dl) | 63.8 ± 13.8 | 63.0 ± 14.0 | (NS) |
 | LDL (mg/dl) | 119.2 ± 26.3 | 122.7 ± 23.4 | (NS) |
 | Treatment (−), n (%) | 259 (75.3 %) | 477 (59.8 %) |  |
 | T-CHO (mg/dl) | 220.2 ± 33.8 | 218.0 ± 34.5 | (NS) |
 | TG (mg/dl) | 123.2 ± 69.1 | 129.3 ± 66.9 | (NS) |
 | HDL (mg/dl) | 59.1 ± 13.6 | 57.4 ± 13.1 | (NS) |
 | LDL (mg/dl) | 144.2 ± 30.1 | 143.3 ± 30.5 | (NS) |
IGT | Treatment (+), n (%) | 17 (4.9Â %) | 72 (9.0Â %) | <0.05 |
 | FBS (mg/dl) | 124.1 ± 25.4 | 138.1 ± 33.4 | (<0.05) |
 | HbA1c (NGSP) (%) | 6.9 ± 0.9 | 7.2 ± 1.1 | (NS) |
 | Treatment (−), n (%) | 327 (95.1 %) | 725 (91.0 %) |  |
 | FBS (mg/dl) | 105.6 ± 13.0 | 105.5 ± 16.2 | (NS) |
 | HbA1c (NGSP) (%) | 5.9 ± 0.5 | 6.0 ± 0.7 | (NS) |